A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Their analysis revealed that patients with low- and medium-risk phenotypes, which are machine learning-based traits used to assess the underlying prognosis of a patient, had survival times and ...